INC Research Holdings, Inc. stock price

INC Research Holdings, Inc. latest news:


  • 11/17/2017 00:16:00

    Six million see credit extended without consent

    More than six million people have had their credit card limits increased without asking for it in the last year, research from Citizens Advice suggests.

  • 11/16/2017 17:01:32

    Call to end 'deadweight' research and development tax breaks

    Up to 80% of tax credits for research subsidises spending which would have happened anyway, report says.

  • 11/15/2017 17:45:34

    CAST studies how robots could work better with people

    A new research lab is looking to find the best ways to train robots to work with people.

  • 11/14/2017 17:07:32

    Green planet

    The United Arab Emirates' space research is turning to growing food on Mars.

  • 11/14/2017 15:26:56

    Lam Research to buy back up to $2 billion in stock, hikes dividend

    Lam Research Corp. on Tuesday said it will buy back up to $2 billion in shares over the next 12 to 18 months. Its board also approved raising the quarterly dividend by 11% to 50 cents a share. The dividend will be paid on Jan. 10 to shareholders of record on Dec. 6. Shares of Lam Research gained 1.7% after hours. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 11/14/2017 15:12:33

    BRIEF-Lam Research announces $2.3 bln capital return program

    Lam Research Corp(LRCX): * Lam Research Corporation(LRCX) announces $2.3 billion capital return program.

  • 11/14/2017 09:09:32

    Over-50s caught in 'unemployment trap'

    Older workers are more likely to be out of work and have trouble finding a new job, research finds.

  • 11/13/2017 14:30:13

    BRIEF-Proqr announces proposed public offering of ordinary shares

    Proqr Therapeutics Nv(PRQR). * Proqr announces proposed public offering of ordinary shares. * Proqr - To use proceeds from both offerings to fund clinical trials, ongoing research & development activities​ Source text for Eikon: Further company coverage:

  • 11/10/2017 00:49:00

    METALS-Copper holds above 1-month low as weaker dollar lifts metals

    (Adds Shanghai closing prices, updates London prices) MELBOURNE/BEIJING, Nov 10 (Reuters) - London Metal Exchange copper held above one-month lows on Friday as a weaker dollar broadly lifted base metals, although it remained on track for a weekly loss. "Copper prices will continue to trade sideways over the coming weeks as a stronger U.S. dollar outlook and weakening Chinese imports of refined copper weigh on prices," said BMI Research in a report. "High-frequency indicators such as

  • 11/09/2017 20:13:31

    METALS-Copper prices pick up from 1-mth low as weaker dollar lifts metals

    (Adds comment, detail) MELBOURNE, Nov 10 (Reuters) - London Metal Exchange copper held above one-month lows on Friday as a weaker dollar broadly lifted base metals, although it remained on track for a weekly loss. "Copper prices will continue to trade sideways over the coming weeks as a stronger U.S. dollar outlook and weakening Chinese imports of refined copper weigh on prices," said BMI Research in a report. "High-frequency indicators such as stable stock levels, a persistently ne

  • 11/09/2017 14:56:43

    Sanford Health creates $1M medical research award

    Sanford Health is creating a $1 million global medical research prize to honor advancements in medicine, one of the largest philanthropic awards in the world.

  • 11/09/2017 07:05:48

    Ubiquiti's stock slumps after results beat expectations by outlook falls short

    Shares of Ubiquiti Networks Inc. slumped 3.7% in premarket trade Thursday, after the network technology company reported fiscal first-quarter results that beat expectations, but provided a downbeat revenue outlook. Net income for the quarter to Sept. 30 rose to $74.93 million, or 92 cents a share, from $71.8 million, or 86 cents a share, in the same period a year ago. Excluding non-recurring items, adjusted earnings per share of 92 cents was above the FactSet consensus of 86 cents. Revenue rose 20% to $245.9 million, beating the FactSet consensus of $235.5 million, as 50% growth in enterprise technology revenue helped offset a 0.6% decline in service provider technology revenue. The company said it expects second-quarter revenue of $240 million to $250 million, which is below the FactSet consensus of $252 million. The closed Monday at $66.36, just shy of its Aug. 8 record close of $66.44. The stock had tumbled to a 3-month low in mid-September after short seller Andrew Left of Citron Research called the company a "fraud," then started recovering later that month after Ubiquiti Chief Executive Robert Pera vigorously defended the company. The stock has rallied 13% year to date through Wednesday, while the S&P 500 has gained 16%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 11/09/2017 04:34:48

    BRIEF-Inc Research Holdings qtrly GAAP diluted loss per share of $1.70‍​

    Inc Research Holdings Inc. * Qtrly GAAP diluted loss per share of $1.70‍​. * Qtrly combined company adjusted diluted eps of $0.54‍​. * Inc Research Holdings - Net service revenue for the three months ended September 30, 2017 increased by $332.7 million, or 128.2%, to $592.2 million‍​. * Inc Research Holdings Inc sees Q4 net service revenue $738.0 million to $768.0 million​. * Inc ...

  • 11/08/2017 08:45:41

    GSK grabs Calico top scientist and Roche veteran as new R&D head

    * Hal Barron to join GSK as head of research on Jan. 1. * Move reflects CEO Walmsley's drive to improve pharma R&D. * Current R&D head Vallance leaving for top UK science job. By Ben Hirschler.

  • 11/07/2017 19:22:50

    BRIEF-ACM Research closes IPO of 2 mln class A shares at $5.60/share

    ACM Research Inc(ACMR) - * ACM RESEARCH ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT. * ‍CLOSING OF ITS IPO OF 2 MILLION SHARES OF ITS CLASS A COMMON STOCK AT A PRICE TO PUBLIC OF $5.60 PER SHARE​ Source text for Eikon: Further company coverage:

  • 11/07/2017 17:05:01

    Undercover consumer

    How a Turkish company is helping to change market research by turning member of the public into secret shoppers and product testers.

  • 11/07/2017 14:00:46

    WHO seeks new director for cancer agency facing U.S. scrutiny

    The World Health Organization is seeking a new leader for its France-based cancer research agency to replace the current director, Chris Wild, from January 2019.

  • 11/07/2017 13:49:28

    Oracle tapping corporate bond market with deal that could total $10 billion

    Oracle Corp. tapped the corporate bond market Tuesday with a deal expected to total about $10 billion, according to research firm CreditSights. That would eclipse the $7 billion offering from Apple Inc. on Monday. Initial price talk on the Oracle notes suggested they will price 10 to 17.5 basis points wider than the Apple notes. Oracle is offering five tranches, including a 30-year tranche. CreditSights reiterated a market perform recommendation on the new deal and said it would recommend participating as long as final pricing is 5 basis points wider than Apple priced. Oracle's most active bonds, the 2.650% notes that mature in July of 2026, were last trading at 96.75 cents on the dollar to yield 3.079%, or at a spread of 77 basis points over comparable Treasurys, according to MarketAxess. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 11/07/2017 09:38:00

    From Post-it Notes To Algorithms: How Automation Is Changing Legal Work

    Lawyers are spending less time doing research than they used to, thanks to technology. The next big change will be to automate the process of doing wills, trusts and real estate closings, experts say.

  • 11/06/2017 10:40:15

    Apple Strength Moving to Mac and Services Says Independent Research Firm


  • 11/06/2017 09:14:45

    Richard Berner to leave Treasury research office at end of year

    Richard Berner will step down from his position as director of the Office of Financial Research at the Treasury Department at the end of this year, Treasury said Monday. Berner was confirmed by the Senate for the position in January 2013. In a statement, Treasury Secretary Steven Mnuchin said Berner was "instrumental" in the launch of the office, which was designed to serve the Financial Stability Oversight Council. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 11/06/2017 09:07:55

    Apple is tapping the bond market with deal that may raise $7 billion: CreditSights

    Apple Inc. is again tapping the bond market with a six-part deal of fixed-rate notes that could raise about $7 billion, CreditSights said Monday. The company is planning to issue 2-year, 3-year, five-year, seven-year, 10-year and 30-year notes, said the research firm. "The timing is good for Apple given its excellent fourth-quarter results and strong initial indications for iPhone X demand," analyst Jordan Chalfin wrote in commentary. "However, it's unusual for Apple to be so active in the debt markets in the second half of the calendar year. Apple is clearly not waiting on tax reform which the GOP is hoping to be effective for January 1, 2018." CreditSights is sticking with a market perform recommendation on Apple's bonds, and remains cautious on the longer maturities, he said. On the equity side, Apple shares were up 1.2% Monday, while the S&P 500 was up 0.1% and the Dow Jones Industrial Average was up 0.02%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 11/02/2017 15:52:30

    BRIEF-Research Frontiers Inc reports qtrly ‍loss per share $0.01​

    * Research Frontiers Inc reports third quarter 2017 financial results

  • 11/01/2017 09:33:37

    Russians used Facebook the way other advertisers do: By tapping into its data-mining machine

    Russia's Kremlin-linked Internet Research Agency used the data Facebook users reveal about themselves to target inflammatory messages to unsuspecting Americans.        

  • 10/30/2017 10:33:20

    Apple touches record as brokerages bullish on iPhone X demand

    Several analysts downplayed concerns about Apple Inc's (AAPL) iPhone X production issues and were bullish on demand and sales, pushing the company's shares to a record on Monday. The Cupertino-based company does not provide pre-order figures on iPhones, leaving investors and analysts in the dark in trying to track output through research with its suppliers, consumer surveys and other industry indicators.

  • 10/26/2017 18:40:10

    UPDATE 1-Volatility fails to scare investors in U.S. stock, bond funds -Lipper

    (Adds details on ETFs and mutual funds, analyst quote, table, byline) By Trevor Hunnicutt NEW YORK, Oct 26 (Reuters) - Investors endured jolts to both stocks and bonds, pouring even more cash into funds tracking both markets during the latest week, according to Lipper data released on Thursday. U.S.-based stock funds pulled in $4.7 billion and taxable-bond funds attracted $3.7 billion during the week ended Oct. 25, according to the research service. Rates on U.S. government debt

  • 10/26/2017 14:01:54

    BRIEF-Acacia Research reports Q3 GAAP earnings $3.13/shr

    Acacia Research Corp. * Acacia Research reports third quarter financial results. * Q3 non-GAAP earnings per share $3.31. * Q3 GAAP earnings per share $3.13. * Q3 revenue fell 43 percent to $36.63 million Source text for Eikon: Further company coverage:

  • 10/25/2017 14:12:18

    Amgen quarterly profit tops expectations despite sales decline

    (Reuters) - Amgen Inc reported higher-than-expected third quarter profit on Wednesday as lower research and other costs and higher operating margins helped offset sales declines in some of its biggest established products.

  • 10/25/2017 11:20:20

    Boeing's stock suffers 2nd-biggest price drop after 'dull' results

    Shares of Boeing Co. tumbled $9.77, or 3.7%, in afternoon trade Wednesday, enough to make it the biggest percentage decliner among Dow Jones Industrial Average components, as better-than-expected third-quarter results couldn't support the recent sharp run up. The percentage decline would be the biggest in 16 months, while the price decline would be the second-biggest in the stock's history, behind only the $11.43 plunge suffered on Jan. 27, 2016. "After last quarter's barnstormer, Boeing's 3Q result is relatively dull," said analyst Robert Stallard, at Vertical Research Partners. The stock had shot up 9.9% on July 26, after Boeing reported second-quarter earnings that were well above estimates, although revenue came up a bit shy. The stock has been on a tear, soaring 25% over the past three months through Tuesday's record close of $266. The stock has still run up 64.5% year to date, the best performer this year among Dow components, while the Dow has climbed 17.8%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 10/24/2017 04:49:31

    Eli Lilly beats profit and sales expectations, as diabetes sales soar 39%

    Eli Lilly & Co. reported Tuesday net income of $555.6 million, or 53 cents a share, down from $778.0 million, or 73 cents a share, in the same period a year ago. Excluding non-recurring items, including asset repairment charges and acquired in-process research and development charges, adjusted earnings per share came to $1.05, above the FactSet consensus of $1.03. Revenue rose 9% to $5.66 billion from $5.19 billion, beating the FactSet consensus of $5.52 billion, as revenue from its diabetes products collectively grew 39%. Among the drug maker's biggest drug sellers, sales of Humalog, Alimta, Cymbalta and Zyprexa beat expectations, while Cialis sales fell short. The company raised its 2017 adjusted EPS outlook to $4.15 to $4.25 from $4.10 from $4.20. The stock, which was still inactive in premarket trade, has gained 2.9% over the past three months, while the SPDR S&P Pharmaceuticals ETF fell 3.9% and the S&P 500 has gained 3.9%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    inContact, Inc.SAAS | Incyte CorporationINCY | Independent Bank Corp.INDB | Independent Bank CorporationIBCP | Independent Bank Group, IncIBTX | Industrial Services of America, Inc.IDSA | Infinera CorporationINFN | Infinity Pharmaceuticals, Inc.INFI | Infinity Property and Casualty CorporationIPCC | Information Services Group, Inc.III |